Western Blotting Market is Expected to Increase from $574.80 Million in 2016 to $737.11 Million in 2021

Global Western blotting market is anticipated to grow at a 5.1% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 574.80 million in 2016 and is expected to reach USD 737.11 million by 2021.The western blot is an extensively used technique in molecular biology, immunogenetics, and other molecular biology fields to identify specific proteins in a sample of tissue homogenate or extract. Synthetic or animal-derived antibodies are created to react with the specific target protein. The sample to be tested is prepared and put together with these antibodies on a membrane. After a gel electrophoresis, if the specific protein is present, it will result in an accordingly stained band on the western blot.

Get a comprehensive overview of the Market: http://www.marketdataforecast.com/market-reports/western-blotting-market-5085/

Increase in research activities and R&D spending by pharmaceutical and biotechnology companies and rising prevalence of HIV/AIDS are the primary drivers of the market. Factors such as growing proteomics market, the growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are further expected to drive the growth of the western blotting market in the coming years. Be that as it may, the emergence of alternative technologies is anticipated to restrain the growth of the market. Furthermore, stringent regulations and requirement of high procedural efficiency for accurate results are likely to challenge the western blotting market in the coming years. However, automation in western blotting instruments is projected to pose lucrative opportunities for the western blotting market.

Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/western-blotting-market-5085/request-sample

The global market for Western Blotting market is segmented into Product, Application and End User. On the basis of product, it is segmented into Instruments and Consumables. The consumables segment is expected to have the largest share in this segment of western blotting market. This is mainly due to factors such as an increase in the use of western blotting in research & diagnosis and rise in the number of incidences of diseases that require western blotting for diagnosis. The western blotting instrument is further segmented into gel electrophoresis instruments, blotting systems, and images. The blotting systems segment is projected to account for the largest share in this market segment. The large share of this segment is attributed to high sensitivity, low run time, and high efficiency.

Inquire Before Buying: http://www.marketdataforecast.com/market-reports/western-blotting-market-5085/inquire

On the basis of application, it is segmented into Biomedical & Biochemical Research and Disease Diagnostics. The biomedical & biochemical research segment is expected to hold the largest share of this segment of western blotting market. This is mainly due to the increase in government spending on proteomics research, and rise in R&D spending by pharmaceutical & biotechnology companies in drug discovery and development. However, the disease diagnostics segment is projected to grow at the highest in the coming years. This can be credited to rise in prevalence and incidences of HIV, HSV, HBV, and Lyme disease, among others. On the basis of end user, it is segmented into Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. Pharmaceutical and biotech companies segment will lead with the maximum share of this market segment. However, research institutions segment is expected to have the highest growth rate, followed by diagnostic laboratories segment with the least share in this market segment.
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Middle East and Africa. North-America accounts for the largest share of the market. This can be attributed to the increase in the prevalence of HIV and Lyme disease, U.S.–China collaborative program for biomedical research, increase in research funding and rising production of genetically modified crops in the U.S., HIV vaccine initiative, and growth in the intensity of pharmaceutical and biopharmaceutical clinical research in Canada. In the coming years, Asia-Pacific region is expected to witness the highest growth in the western blotting market, with emphasis on India, China, and Japan.
Some of the companies dominating the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.